We selected SURMOUNT-5 because its transparent, peer-reviewed, methodologically rigorous, and mirrors real-world GLP-1 use: weekly injections, common health challenges, modern obesity doses, identical background conditions
Walsh Week 4 check-in, how are you feeling
A large, multiyear study that showed semaglutide reduced risk of heart attack and stroke by 20 percent helped Wegovy gain FDA approval as a treatment for cardiovascular disease in March 2024
High-Intensity Exercise: Some studies suggest that high-intensity interval training (HIIT) can boost GLP-1 levels more effectively than steady-state cardio
For example, liver, it takes a long time to repair